143 related articles for article (PubMed ID: 36114441)
1. Association of Concurrent Metabolic Syndrome with Long-term Oncological Prognosis Following Liver Resection for Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Virus Infection: A Multicenter Study of 1753 Patients.
Wang MD; Tang SC; Li C; Sun LY; Xu X; Liang YJ; Liu FB; Gu WM; Wang XM; Zhou YH; Lau WY; Zhang CW; Yao LQ; Diao YK; Gu LH; Shen F; Zeng YY; Yang T
Ann Surg Oncol; 2023 Jan; 30(1):346-358. PubMed ID: 36114441
[TBL] [Abstract][Full Text] [Related]
2. Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Wang MD; Li C; Liang L; Xing H; Sun LY; Quan B; Wu H; Xu XF; Wu MC; Pawlik TM; Lau WY; Shen F; Yang T
Oncologist; 2020 Oct; 25(10):e1541-e1551. PubMed ID: 32472951
[TBL] [Abstract][Full Text] [Related]
3. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
Li T; Wang SK; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Liver Int; 2016 Feb; 36(2):284-92. PubMed ID: 26104132
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival and recurrence after curative resection for hepatocellular carcinoma in patients with chronic hepatitis C virus infection: a multicenter observational study from China.
Zhu H; Xing H; Yu B; Yan WT; Zhang CW; Guan MC; Zhou YH; Wang H; Zhang WG; Zhang YM; Li J; Wang Y; Chen TH; Zeng YY; Lau WY; Liang L; Li C; Yang T
HPB (Oxford); 2020 Dec; 22(12):1793-1802. PubMed ID: 32456976
[TBL] [Abstract][Full Text] [Related]
5. Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study.
Zhang XP; Chai ZT; Feng JK; Zhu HM; Zhang F; Hu YR; Zhong CQ; Chen ZH; Wang K; Shi J; Guo WX; Chen CS; Wu MC; Lau WY; Cheng SQ
Eur J Surg Oncol; 2022 Jan; 48(1):142-149. PubMed ID: 34452770
[TBL] [Abstract][Full Text] [Related]
6. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
7. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
[TBL] [Abstract][Full Text] [Related]
8. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
[TBL] [Abstract][Full Text] [Related]
9. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
Yoo S; Kim JY; Lim YS; Han S; Choi J
J Hepatol; 2022 Oct; 77(4):939-946. PubMed ID: 35643206
[TBL] [Abstract][Full Text] [Related]
10. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.
Kim HS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Park YN; Han DH; Kim KS; Choi JS; Choi GH; Kim HS
Clin Mol Hepatol; 2020 Jan; 26(1):33-44. PubMed ID: 31243939
[TBL] [Abstract][Full Text] [Related]
11. Impact of Surveillance in Chronic Hepatitis B Patients on Long-Term Outcomes After Curative Liver Resection for Hepatocellular Carcinoma.
Li ZL; Wu H; Wei YP; Zhong Q; Song JC; Yu JJ; Li C; Wang MD; Xu XF; Li JD; Han J; Xing H; Lau WY; Wu MC; Shen F; Yang T
J Gastrointest Surg; 2020 Sep; 24(9):1987-1995. PubMed ID: 31388886
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection:
Jia HD; Liang L; Li C; Wu H; Wang H; Liang YJ; Zhou YH; Gu WM; Fan XP; Zhang WG; Chen TH; Chen ZY; Zhong JH; Lau WY; Pawlik TM; Diao YK; Xu QR; Shen F; Zhang CW; Huang DS; Yang T
Front Oncol; 2021; 11():700228. PubMed ID: 34395268
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
Yoon JS; Lee HY; Chung SW; Kim SW; Chang Y; Lee YB; Cho EJ; Lee JH; Yu SJ; Kim H; Yoon JH; Kim YJ
J Gastroenterol Hepatol; 2020 Nov; 35(11):1960-1968. PubMed ID: 32128882
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
[TBL] [Abstract][Full Text] [Related]
15. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection.
Wang XH; Hu ZL; Fu YZ; Hou JY; Li WX; Zhang YJ; Xu L; Zhou QF; Chen MS; Zhou ZG
J Gastroenterol; 2022 Mar; 57(3):185-198. PubMed ID: 35152312
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.
Wu JC; Huang YH; Chau GY; Su CW; Lai CR; Lee PC; Huo TI; Sheen IJ; Lee SD; Lui WY
J Hepatol; 2009 Nov; 51(5):890-7. PubMed ID: 19747749
[TBL] [Abstract][Full Text] [Related]
18. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
19. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
[TBL] [Abstract][Full Text] [Related]
20. A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.
Kao WY; Su CW; Chau GY; Lui WY; Wu CW; Wu JC
World J Surg; 2011 Apr; 35(4):858-67. PubMed ID: 21207029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]